- Home
- ANET vs LLY Comparison
ANET vs LLY Comparison
Compare ANET & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANET | LLY |
|---|---|---|
| Founded | 2004 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.1B | 950.7B |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ANET | LLY |
|---|---|---|
| Price | $133.71 | $986.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 19 |
| Target Price | $173.56 | ★ $1,174.53 |
| AVG Volume (30 Days) | ★ 6.7M | 2.3M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | 23.32 | ★ 95.99 |
| EPS | 2.75 | ★ 22.95 |
| Revenue | $9,005,700,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $28.79 | $27.04 |
| Revenue Next Year | $21.10 | $16.26 |
| P/E Ratio | $48.87 | ★ $42.56 |
| Revenue Growth | 28.60 | ★ 44.70 |
| 52 Week Low | $59.43 | $623.78 |
| 52 Week High | $164.94 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | ANET | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 42.67 |
| Support Level | $120.77 | $978.77 |
| Resistance Level | $139.93 | $1,102.49 |
| Average True Range (ATR) | 5.14 | 24.46 |
| MACD | 0.27 | -2.82 |
| Stochastic Oscillator | 58.45 | 22.52 |
Price Performance
Historical ComparisonAbout ANET Arista Networks Inc.
Arista Networks is a networking equipment provider that mainly sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three-quarters of its sales from North America.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.